Co-organised by Chris Goldsworthy and Professor Paul Martin
Supported by the Institute for Science, Innovation and Society, University of Oxford and the Institute for the Study of the Human, the University of Sheffield.
This workshop draws together expertise in the politics and practice of translating genetic and genomic medicine into clinical practice in the UK. Studies in the fields of science and technology studies, medical anthropology and medical sociology have highlighted the complexity involved in developing and translating new biotechnologies and personalised medicine agendas into healthcare settings. This workshop brings together scholars from these disciplines to facilitate a timely discussion of current developments in the UK with regards to the moves to implement whole genome sequencing into clinical practice via the recently announced national genomic medicine service, as well as to consider the future implications of this transformation for clinical practice, personalised medicine and biotechnology development.
Themes for discussion include:
• How is whole genome sequencing being deployed within clinical-research practice across a variety of contexts in the UK?
• What are the practical clinical consequences of the development of a Genomic Medicine Service following the Genomics England model?
• What political and governance concerns have arisen from both the practice and promise of the 100,000 Genomes Project and the subsequent development of the Genomic Medicine Service?
• What considerations should be made for the implications of a Genomic Medicine Service beyond the clinical setting, in both the research and commercial sectors?
Confirmed participants include:
Andrew Webster (University of York)
Anne Kerr (University of Leeds)
Stuart Hogarth (University of Cambridge)
Adam Hedgecoe (Cardiff University)
Kathleen Job (Cardiff University)
Angus Clarke (Cardiff University)
Sophie Day (Goldsmiths)
Michael Hopkins (University of Sussex)
Catherine Heeney (The University of Edinburgh)
Javier Lezaun (University of Oxford)
Teresa Finlay (University of Oxford)
Michael Morrison (University of Oxford)
Participation is limited; please contact Chris Goldsworthy for more information:
